Finding What Drives the Spread of a Severe Parasitic Disease in Eastern Africa

Analyzing the Potential of AlphaFold in Drug Discovery

Researcher Aims to Develop More Effective TB Vaccine

$5 Million NIH Center Grant Will Support Next Generation TB Research

$3 Million Grant Awarded to Study Links between COVID and HIV

Researchers Identify Immune Cell That Helps Kill Bladder Cancer Tumors

Kovina Therapeutics Receives Grant from NIH to Advance Human Papillomavirus Premalignant Infection Treatments

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.kovina.com/press/kovina-therapeutics-receives-grant-from-nih-to-advance-human-papillomavirus-premalignant-infection-treatments
Research Institution
Kovina Therapeutics
Short Title
Kovina Therapeutics Receives Grant from NIH to Advance Human Papillomavirus Premalignant Infection Treatments
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Beyond AlphaFold—AI Excels at Creating New Proteins

How to Stop the Next Pandemic Before It Starts

Community Virus Surveillance Can Double the Data of Vaccine Trials

Subscribe to